Literature DB >> 7884921

Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia.

R J Cohrs1, M B Barbour, R Mahalingam, M Wellish, D H Gilden.   

Abstract

Reverse transcriptase-linked PCR was used to determine the prevalence of varicella-zoster virus (VZV) gene 21 transcription in latently infected human ganglia. Under conditions wherein reverse transcriptase-linked PCR detected > or = 1,000 transcripts, VZV gene 21 RNA, but not VZV gene 40 RNA, was found in ganglia but not other tissues from five of seven humans.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7884921      PMCID： PMC188953     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  24 in total

1.  The herpes simplex virus UL37 protein is phosphorylated in infected cells.

Authors:  A G Albright; F J Jenkins
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

2.  The herpes simplex virus type 1 UL37 gene product is a component of virus particles.

Authors:  J McLauchlan; K Liefkens; N D Stow
Journal:  J Gen Virol       Date:  1994-08       Impact factor: 3.891

3.  Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies.

Authors:  B Forghani; K W Dupuis; N J Schmidt
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

4.  Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript.

Authors:  R J Cohrs; K Srock; M B Barbour; G Owens; R Mahalingam; M E Devlin; M Wellish; D H Gilden
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase.

Authors:  T I Ng; L Keenan; P R Kinchington; C Grose
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Varicella-zoster virus DNA polymerase and major DNA-binding protein genes have overlapping divergent promoters.

Authors:  J L Meier; S E Straus
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain.

Authors:  L P Perera; J D Mosca; W T Ruyechan; G S Hayward; S E Straus; J Hay
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia.

Authors:  R Cohrs; R Mahalingam; A N Dueland; W Wolf; M Wellish; D H Gilden
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

9.  The transcriptional activation domain of varicella-zoster virus open reading frame 62 protein is not conserved with its herpes simplex virus homolog.

Authors:  J I Cohen; D Heffel; K Seidel
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Varicella-zoster virus transcription in human trigeminal ganglia.

Authors:  J L Meier; R P Holman; K D Croen; J E Smialek; S E Straus
Journal:  Virology       Date:  1993-03       Impact factor: 3.616
View more
  32 in total

1.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Neutralizing anti-gH antibody of Varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency.

Authors:  Kimiyasu Shiraki; Tohru Daikoku; Masaya Takemoto; Yoshihiro Yoshida; Kazuhiro Suzuki; Yasushi Akahori; Toshiomi Okuno; Yoshikazu Kurosawa; Yoshizo Asano
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR.

Authors:  R J Cohrs; J Randall; J Smith; D H Gilden; C Dabrowski; H van Der Keyl; R Tal-Singer
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation.

Authors:  Christina L Stallings; Gregory J Duigou; Anne A Gershon; Michael D Gershon; Saul J Silverstein
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 5.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

6.  In vitro antiviral activity of honey against varicella zoster virus (VZV): A translational medicine study for potential remedy for shingles.

Authors:  Aamir Shahzad; Randall J Cohrs
Journal:  Transl Biomed       Date:  2012

7.  Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency.

Authors:  Hitoshi Sato; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  BAG3, a host cochaperone, facilitates varicella-zoster virus replication.

Authors:  Christos A Kyratsous; Saul J Silverstein
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  Nuclear import of the varicella-zoster virus latency-associated protein ORF63 in primary neurons requires expression of the lytic protein ORF61 and occurs in a proteasome-dependent manner.

Authors:  Matthew S Walters; Christos A Kyratsous; Shilin Wan; Saul Silverstein
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  Array analysis of viral gene transcription during lytic infection of cells in tissue culture with Varicella-Zoster virus.

Authors:  Randall J Cohrs; Michael P Hurley; Donald H Gilden
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.